Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Deficit) (Details Narrative)

v3.25.0.1
Stockholders’ Equity (Deficit) (Details Narrative) - USD ($)
 3 Months Ended
Dec. 10, 2024
Nov. 07, 2024
May 02, 2024
Oct. 26, 2023
Dec. 31, 2024
Dec. 31, 2023
Jun. 30, 2024
Subsidiary, Sale of Stock [Line Items]              
Proceeds from sale of common stock         $ 7,711,161 $ 3,838,870  
Issuance of share, value         $ 7,622,619 3,916,943  
Warrant, shares         5,789,600    
Purchase and Registration Rights Agreement [Member]              
Subsidiary, Sale of Stock [Line Items]              
Common stock avialable to be sold         $ 24,900,000    
Underwriting Agreement [Member] | Chardan Capital Markets LLC [Member]              
Subsidiary, Sale of Stock [Line Items]              
Shares for sale   155,000          
Proceeds from offering   $ 4,200,000          
Common Stock [Member]              
Subsidiary, Sale of Stock [Line Items]              
Issuance of share, value         $ 105 $ 16  
Net share settlement of warrants, shares         1,209 1,795  
Sale of common stock, net of issuance costs, shares         1,050,500 163,281  
Common Stock [Member] | Purchase and Registration Rights Agreement [Member]              
Subsidiary, Sale of Stock [Line Items]              
Shares for sale         0    
Issuance of share, value     $ 25,000,000.0        
Volume weighted average price discount percentage     4.00%        
Prefunded Warrant [Member] | Underwriting Agreement [Member] | Chardan Capital Markets LLC [Member]              
Subsidiary, Sale of Stock [Line Items]              
Warrants to purchase common stock   956,111          
Offering price per share   $ 4.4999          
Exercisable price   $ 0.0001          
Common Warrant [Member] | Underwriting Agreement [Member] | Chardan Capital Markets LLC [Member]              
Subsidiary, Sale of Stock [Line Items]              
Warrants to purchase common stock   2,222,222          
Offering price per share   $ 4.50          
Exercisable price   $ 4.50          
Warrants term   5 years          
Common Stock Warrants [Member]              
Subsidiary, Sale of Stock [Line Items]              
Warrant, shares         32,375   187,500
Net share settlement of warrants, shares         2,419 3,590  
Sale of common stock, net of issuance costs, shares         1,209 1,795  
Prefunded October 2023 Warrants [Member]              
Subsidiary, Sale of Stock [Line Items]              
Warrants to purchase common stock         99,687 192,187  
Exercisable price         $ 0.0008 $ 0.0008  
Warrant, shares         155,125    
Pre-funded Warrants [Member]              
Subsidiary, Sale of Stock [Line Items]              
Number of warrant exercised         1,273,436    
Holder [Member] | Common Stock Warrants [Member]              
Subsidiary, Sale of Stock [Line Items]              
Forfeited warrants, shares           4,302  
October Offering [Member] | Underwriters [Member]              
Subsidiary, Sale of Stock [Line Items]              
Proceeds from sale of common stock       $ 3,900,000      
Warrants to purchase common stock       10,664      
Exercisable price       $ 16.00      
Warrants term       5 years      
October Offering [Member] | Underwriters [Member] | Common Stock [Member]              
Subsidiary, Sale of Stock [Line Items]              
Shares for sale       163,281      
October Offering [Member] | Underwriters [Member] | Prefunded Warrant [Member]              
Subsidiary, Sale of Stock [Line Items]              
Warrants to purchase common stock       192,187      
Offering price per share       $ 12.7992      
Exercisable price       $ 0.0008      
October Offering [Member] | Underwriters [Member] | Common Warrant [Member]              
Subsidiary, Sale of Stock [Line Items]              
Warrants to purchase common stock       710,931      
Offering price per share       $ 12.80      
Exercisable price       $ 12.80      
Warrants term       5 years      
October Offering [Member] | Underwriters [Member] | June 2024 Inducement Offer [Member]              
Subsidiary, Sale of Stock [Line Items]              
Warrants exercise price decrease       $ 9.60      
Registered Direct Offering [Member]              
Subsidiary, Sale of Stock [Line Items]              
Offering price per share $ 2.23            
Proceeds from offering $ 3,500,000            
Registered Direct Offering [Member] | Prefunded Warrant [Member]              
Subsidiary, Sale of Stock [Line Items]              
Offering price per share $ 2.2299            
Registered Direct Offering [Member] | Prefunded Warrant [Member]              
Subsidiary, Sale of Stock [Line Items]              
Shares for sale 768,000            
Warrants to purchase common stock 317,325            
Exercisable price $ 0.0001            
Registered Direct Offering [Member] | Warrant [Member]              
Subsidiary, Sale of Stock [Line Items]              
Warrants to purchase common stock 1,085,325            
Exercisable price $ 2.10            
Warrants term 5 years            
Private Placement [Member]              
Subsidiary, Sale of Stock [Line Items]              
Offering price per share $ 2.23            
Private Placement [Member] | Prefunded Warrant [Member]              
Subsidiary, Sale of Stock [Line Items]              
Shares for sale 127,500            
Warrants to purchase common stock 545,500            
Exercisable price $ 0.0001            
Private Placement [Member] | Warrant [Member]              
Subsidiary, Sale of Stock [Line Items]              
Warrants to purchase common stock 673,000            
Exercisable price $ 2.10            
Warrants term 5 years